These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29350882)

  • 1. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease.
    Kato M; Ayusawa M; Watanabe H; Komori A; Abe Y; Nakamura T; Kamiyama H; Takahashi S
    Pediatr Int; 2018 Apr; 60(4):342-348. PubMed ID: 29350882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting N-terminal pro-brain natriuretic peptide elevation in the acute phase of Kawasaki disease.
    Yanagisawa D; Ayusawa M; Kato M; Watanabe H; Komori A; Abe Y; Nakamura T; Kamiyama H; Takahashi S
    Pediatr Int; 2016 Nov; 58(11):1105-1111. PubMed ID: 26991905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY; Du JB; Chen YH; Li WZ
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
    Reddy M; Singh S; Rawat A; Sharma A; Suri D; Rohit MK
    Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.
    Kwon H; Lee JH; Jung JY; Kwak YH; Kim DK; Jung JH; Chang I; Kim K
    Eur J Pediatr; 2016 Dec; 175(12):1997-2003. PubMed ID: 27798729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP).
    Desjardins L; Dionne A; Meloche-Dumas L; Fournier A; Dahdah N
    Pediatr Cardiol; 2020 Jun; 41(5):947-954. PubMed ID: 32172336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global left ventricular longitudinal strain is closely associated with increased neurohormonal activation after acute myocardial infarction in patients with both reduced and preserved ejection fraction: a two-dimensional speckle tracking study.
    Ersbøll M; Valeur N; Mogensen UM; Andersen M; Greibe R; Møller JE; Hassager C; Søgaard P; Køber L
    Eur J Heart Fail; 2012 Oct; 14(10):1121-9. PubMed ID: 22753861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.
    Dionne A; Meloche-Dumas L; Desjardins L; Turgeon J; Saint-Cyr C; Autmizguine J; Spigelblatt L; Fournier A; Dahdah N
    Pediatr Int; 2017 Mar; 59(3):265-270. PubMed ID: 27589358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.
    Jung JY; Ham EM; Kwon H; Kwak YH; Kim DK; Lee JH; Jung JH
    Am J Emerg Med; 2019 Mar; 37(3):468-471. PubMed ID: 29903669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease.
    McNeal-Davidson A; Fournier A; Spigelblatt L; Saint-Cyr C; Mir TS; Nir A; Dallaire F; Cousineau J; Delvin E; Dahdah N
    Pediatr Int; 2012 Oct; 54(5):627-33. PubMed ID: 22414326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between N-terminal pro-B-type natriuretic peptide and cardiac function in adults with corrected tetralogy of Fallot.
    Eindhoven JA; Menting ME; van den Bosch AE; Cuypers JA; Ruys TP; Witsenburg M; McGhie JS; Boersma E; Roos-Hesselink JW
    Int J Cardiol; 2014 Jul; 174(3):550-6. PubMed ID: 24798786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.
    Iwashima S; Ishikawa T
    World J Pediatr; 2013 Aug; 9(3):239-44. PubMed ID: 23335186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S; Luo C; Zhou K; Hua Y; Wu M; Liu L; Liu X; Wang C
    Pediatr Rheumatol Online J; 2019 Sep; 17(1):65. PubMed ID: 31533770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease.
    Lee SH; Song ES; Yoon S; Hong S; Cho HJ; Yang EM; Eom GH; Kang G; Cho YK
    Dis Markers; 2017; 2017():6263121. PubMed ID: 29358841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of Serum NT-proBNP and Endogenous H₂S for Predicting Coronary Artery Lesions in Pediatric Kawasaki Disease.
    Song HB; Zhang YD; Dong QW; Han LP; Qi RF; Bi BB; Ma L; Ma L; Zhang H
    J Coll Physicians Surg Pak; 2020 Jan; 30(1):37-40. PubMed ID: 31931930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.